Safety and Tolerability of MK-5478 in Participants With Hypertension (5478-001)

NCT01025843 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: MK-5478
DRUG: Comparator: Candesartan cilexetil
DRUG: Comparator: Pbo

Sponsor

Merck Sharp & Dohme LLC